Anil Sehgal

Title: Anil Sehgal: Innovator in Tumorigenesis Research

Introduction

Anil Sehgal is a prominent inventor based in Dublin, California, known for his significant contributions to the field of tumorigenesis research. With a total of six patents to his name, he has made remarkable strides in understanding the role of the CXCR-4 gene in cancer development.

Latest Patents

Sehgal's latest patents focus on therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis. His inventions relate to the identification of a novel role of CXCR-4 in cell transformation and aberrant cellular proliferation. Specifically, these patents address the altered gene expression of CXCR-4 in various primary tumors and cell lines derived from tumors. Furthermore, his work highlights the surprising discovery that inhibiting CXCR-4 gene expression or activity in transformed cells can reverse the transformed phenotype.

Career Highlights

Throughout his career, Anil Sehgal has worked with notable organizations, including Northwest Biotherapeutics, Inc. and Northwest Hospital. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Sehgal has collaborated with esteemed colleagues such as Alton L. Boynton and Gerald P. Murphy, further enhancing the impact of his work in the field.

Conclusion

Anil Sehgal's innovative research and patents have made a substantial impact on the understanding of tumorigenesis, particularly through the lens of the CXCR-4 gene. His contributions continue to pave the way for advancements in therapeutic and diagnostic applications in cancer research.